Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: A systematic review of the literature

Health Technology Assessment

Volumn 5, Issue 26, 2001, Pages

  Brocklebank, D ^a   Ram, F ^a   Wright, J ^a   Barry, P ^a   Cates, C ^a   Davies, L ^a   Douglas, G ^a   Muers, M ^a   Smith, D ^a   White, J ^a  

^a BRADFORD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AEROBEC; AEROBEC FORTE; ANTIASTHMATIC AGENT; ASMASAL; BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BECLOMETASONE DIPROPIONATE PLUS SALBUTAMOL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID DERIVATIVE; CROMOGEN; CROMOGLYCATE DISODIUM; FENOTEROL; FENOTEROL PLUS IPRATROPIUM BROMIDE; FLUTICASONE; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; FORMOTEROL FUMARATE; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; ISOETARINE; ISOPRENALINE; ORCIPRENALINE; OXICONAZOLE; OXITROPIUM BROMIDE; REPROTEROL; RESPONTIN; SALBUTAMOL; SALBUTAMOL SULFATE; SALMETEROL; SALMETEROL XINAFOATE; TERBUTALINE; UNCLASSIFIED DRUG;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RESPONSE; ECONOMIC EVALUATION; HEALTH CARE COST; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INHALER; LUNG VOLUME; METERED DOSE INHALER; NEBULIZER; PRESCRIPTION; REVIEW; SYSTEMIC DISEASE;

EID: 0034763042     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta5260     Document Type: Review

References (354)

1. The British guidelines on asthma management
2. The inhalation device influences lung deposition and bronchodilating effect of terbutaline
3. Gamma scintigraphy in the evaluation of pharmaceutical dosage forms
4. A comparison of lung deposition patterns between different asthma inhalers
5. Discrepancy between in vitro and in vivo dose variability for a pressurized metered dose inhaler and a dry powder inhaler
6. In vitro properties of pressurized metered dose inhalers with and without spacer devices
7. Inhalation drug delivery from seven different spacer devices
8. Effect of add-on devices for aerosol drug delivery: Deposition studies and clinical aspects
9. How well do in vitro particle size measurements predict drug delivery in vivo?
10. Problems with inhalation drug delivery
11. Variability in lung deposition of inhaled drug, within and between asthmatic patients, with a pMDI and dry powder inhaler, Turbuhaler
12. Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction
13. The bronchodilator response from inhaled terbutaline is influenced by the mass of small particles: A study on a dry powder inhaler (Turbuhaler)
14. Predicting in vivo lung deposition of cromlyn sodium from in vitro estimates
15. In vitro deposition and clinical efficacy of two sodium cromoglycate inhalation powders
16. In vitro inhalation behaviour and therapeutical response of salbutamol particles administered from two metered dose aerosols
17. Apparatus and method for measuring regional distribution of therapeutic aerosols and comparing delivery systems
18. Aerosol particle generation from dry powder inhaler - Can they equal pressurized metered dose inhalers?
19. Impact of oropharyngeal deposition on inhaled dose
20. Metered dose inhaler aerosol deposition in a model of the human respiratory system and a comparison with clinical deposition studies
21. Effect of inlet throat on the correlation between measured fine particle dose and lung deposition
22. Comparison of inhaled corticosteroids
23. New perspectives on inhaled drug delivery and systemic bioactivity
24. The transition to CFC-free inhalers
25. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS
26. The use of inhaled corticosteroids in childhood asthma
27. The use of inhaled corticosteroids in adults with asthma
28. Inhaler devices for asthma
29. Efficacy and safety of beclomethasone dipropionte (BDP) delivered via a novel dry powder inhaler (Clickhaler) in paediatric patients with asthma
30. Importance of the inhalation device on the effect of budesonide
31. Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler
32. Dose response to inhaled terbutaline powder and peak inspiratory flow through Turbuhaler® in children with mild to moderate asthma
33. Drug delivery to various age groups of children from two different inhalers
34. A clinical comparison of beclomethasone dipropionate delivered by pressurized aerosol and as a powder from a Rotahaler
35. Becotide or Becodisks? A controlled study in general practice
36. Delivery devices for inhaled asthma medication. Clinical implications of differences in effectiveness
37. Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma
38. Pulmonary deposition and clinical response of 99m Tc-labelled salbutamol delivered from a novel multiple dose powder inhaler
39. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant
40. Evaluation of fluticasone propionate (500 microg day-1) administered either as a dry powder via a Diskhaler® or pressurized inhaler and compared with beclomethasone diprionate (1000 microg day-1) administered by pressurized inhaler
41. A new beclomethasone dipropionate multidose inhaler in the treatment of bronchial asthma
42. Beclomethasone in asthma: A comparison of two methods of administration
43. Beclomethasone dipropionate aerosol compared with dry powder in the treatment of asthma
44. Clinical comparison of inhaled budesonide delivered either via pressurized metered dose inhaler or Turbuhaler
45. Inhalation treatment with budesonide in asthma. A comparison of Turbuhaler and metered dose inhalation with Nebuhaler
46. Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone beclomethasone
47. Switch to non-CFC inhaled corticosteroids: A comparative efficacy study of HFA-BDP and CFC-BDP metered-dose inhalers
48. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose
49. Hydrofluoroalkane-134a beclomethasone dipropionate, 400μg, is as effective chlorofluorocarbon beclomethasone dipropionate, 800μg, for the treatment of moderate asthma
50. A comparative study of the efficacy of beclomethasone dipropionate delivered from a breath activated and conventional metered dose inhaler in asthmatic patients
51. Beclomethasone dipropionate dry-powder inhalation compared with conventional aerosol in chronic asthma
52. Equivalence of two steroid-containing inhalers: Easyhaler multidose powder inhaler compared with conventional aerosol with large volume spacer
53. A comparison of fluticasone propionate when delivered by either the metered-dose inhaler or the Diskhaler inhaler in the treatment of mild-to-moderate asthma
54. A clinical comparison of aerosol and powder administration of beclomethasone dipropionate in asthma
55. Comparison of a multidose powder inhaler containing beclomethasone dipropionate (BDP) with a BDP metered dose inhaler with spacer in the treatment of asthmatic patients
56. Comparison of the antiasthmatic, oropharyngeal and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler
57. Clinical evaluation of CFC-free metered dose inhalers
58. Influence of spacer device on drug delivery to young children with asthma
59. Methodological aspects on clinical trials with inhaled corticosteroids: Results of two comparisons between two steroid aerosols in patients with asthma
60. Controlled trial of budesonide given by the nebuhaler in preschool children with asthma
61. Cost-effectiveness analysis of a dry powder inhaler (Turbuhaler™) versus a pressurized metered dose inhaler inpatients with asthma
62. Efficacy of chlorofluorocarbon-free beclomethasone dipropionate 400μg/day delivered as an extrafine aerosol in adults with moderate asthma
63. Fluticason bei der behandlung des asthma in der niedergelassenen
64. A 1-year comparison of turbuhaler vs pressurized metered-dose inhaler in asthmatic patients
65. Clinical efficacy and safety of budesonide Turbuhaler as compared to MDIs in children
66. Wirksamkeit, vertraglichkeit und handhabbarkeit von budesonid turbohaler bei patienten mit obstruktiven atemwegserkrankungen
67. Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma
68. Comparative asthma control and certainty of dose delivery with two breath-actuated asthma inhalers
69. Fluticasonpropionat dosieraerosol. Wirksamkeit und vertraglichkeit bei patienten mit asthma bronchiale
70. Clinical equivalence of a novel multiple dose powder inhaler versus a conventional metered dose inhaler on bronchodilating effects of salbutamol
71. Influence of inspiratory capacity on bronchodilation via Turbuhaler or pressurized metered-dose inhaler in asthmatic children
72. Comparison of inhaled terbutaline administered by either the turbuhaler dry powder or a metered-dose inhaler with spacer in preschool children with asthma
73. A double-blind comparison between a new multi-dose powder inhaler (turbuhaler) and metered dose inhaler in children with asthma
74. A comparison of the bronchodilatory effect of 50 and 100 μg salbutamol via turbuhaler and 100 μg salbutamol via pressurized metered dose inhaler in children with stable asthma
75. A comparison of terbutaline inhaled by turbuhaler and by a chlorofluorocarbon (CFC) inhaler in children with exercise-induced asthma
76. Comparison of a new multidose powder inhaler with a pressurized aerosol in children with asthma
77. Treatment of asthma in pre-school children with inhalation of terbutaline in turbuhaler compared with nebuhaler
78. Albuterol treatment for children with asthma: A comparison of inhaled powder and aerosol
79. Albuterol aerosol versus albuterol Rotacaps in exercise-induced bronchospasm in children
80. Efficacy of a new non-ozone depleting formulation for salbutamol
81. Inhaled powder compared with aerosol administration of fenoterol in asthmatic children
82. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
83. Albuterol in HFA propellant (ALB-HFA) 180mcg QID is comparable in safety and efficacy to albuterol in CFC propellant (ALB-CFC) 180mcg QID in adolescent and adult patients with asthma
84. Comparison of the bronchoprotective effect of single doses of albuterol/HFA 134a and albuterol/CFC against exercise induced bronchoconstriction
85. Comparison of single doses of HFA-134a propellant and CFC salbutamol in mild to moderate asthmatic patients
86. In vivo evaluation of the new multiple dose powder inhaler and the rotahaler using the gamma scintigraphy
87. Long-term comparison of salbutamol powder with salbutamol aerosol in asthmatic out-patients
88. Fenoterol inhalation powder and aerosol in the treatment of asthma
89. A comparison of fenoterol powder capsules and fenoterol metered dose spray in bronchial asthma
90. The effect of powder aerosol compared to pressurized aerosol
91. Comparison of the bronchodilating efficacies of a novel salbutamol metered dose powder inhaler and a pressurized metered dose aerosol with a spacer
92. Bricanyl turbuhaler in the treatment of asthma: A six week multi-centre study carried out in Sweden, the United Kingdom, Denmark, Norway and Finland
93. Safety and efficacy of a high cumulative dose of salbutamol inhaled via turbuhaler or via a pressurized metered-dose inhaler in patients with asthma
94. Dose potency relationship of terbutaline inhaled via turbuhaler or via a pressurized metered dose inhaler
95. Turbuhaler: A new device for dry powder terbutaline inhalation
96. Comparison of the bronchodilator effects of salbutamol inhaled as a dry powder and by conventional pressurized aerosol
97. Safety of long-term treatment with HFA albuterol
98. Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol
99. Carry-over biases in clinical pharmacology
100. Fenoterol inhalation powder as an alternative to treatment with the metered dose inhaler
101. Differences in bronchodilating potency of salbutamol in Turbuhaler as compared with pressurized metered-dose inhaler formulation in patients with reversible airway obstruction
102. Comparison of salbutamol rotahaler with conventional pressurized aerosol
103. Crossover trials are only useful when there is a positive correlation between the response to different treatment modalities
104. Albuterol delivered by metered-dose inhaler (MDI), MDI with spacer and rotahaler device - A comparison of efficacy and safety
105. Kinetics of action of salbutamol inhaled from a metered dose inhaler (MDI) and a 'diskhaler'
106. Evaluation of a breath operated powder inhaler
107. Albuterol via turbuhaler versus albuterol via pressurized metered-dose inhaler in asthma
108. Cumulative dose-response study of airomir (salbutamol sulphate in CFC-free system) versus CFC salbutamol sulphate and HFA-134a placebo in patients with asthma
109. Comparison of terbutaline and placebo from a pressurized metered dose inhaler and a dry powder inhaler in a subgroup of patients with asthma
110. Salbutamol by powder or spray inhalation in childhood asthma
111. Long-term effects of therapy on respiratory health
112. Excessive use of inhaled salbutamol: The potential benefits of dose-reduction. A case report
113. Subsensitivity of beta-adrenoceptor responses in asthmatic patients taking regular low dose inhaled salbutamol
114. Regular inhaled beta-agonist treatment in bronchial asthma
115. Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol
116. Regular vs as needed inhaled salbutamol in asthma control
117. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network
118. Effects of long-term inhaled salbutamol therapy on the provocation of asthma by histamine
119. Budesonide administered via Turbohaler and a nebulator (Budesonide handling administered via Turbuhaler or nebulator)
120. Bronchoprotective effect of a single dose of 400mcg salbutamol delivered via the babyhaler spacer device against methacholine challenge in asthmatic children
121. La risposta al broncodilatator spray somministrato direttamente e con distanziatore
122. Terbutaline by metered-dose inhaler: Conventional inhaler versus tube spacer for children with asthma
123. The lung deposition of salbutamol, directly labelled with technetium-99m, delivered by pressurized metered dose and dry powder inhalers
124. A tube spacer to improve inhalation of drugs from pressurized aerosols
125. Comparative efficacy and potency of ipratropium via turbuhaler and pressurized metered-dose inhaler in reversible airflow obstruction
126. Total and regional lung deposition of terbutaline sulphate inhaled via a pressurized MDI or via turbuhaler
127. The effects of salbutamol when given by three different methods of inhalation
128. An open, prospective comparison of beta 2 agonists given via nebuliser, Nebuhaler, or pressurized inhaler by ambulance crew as emergency treatment
129. Salbutamol administered through a new spacer device to prevent exercise-induced asthma
130. Differing bioavailability of salbutamol metered-dose inhalers
131. Clinical comparison of Gentle-haler actuator and aerochamber spacer for metered dose inhaler (MDI) use by asthmatics
132. Double-blind cross-over study of five bronchodilator medications and two delivery methods in stable asthma
133. Lung bioavailability of chlorofluorocarbon free, dry powder and chlorofluorocarbon containing formulations of salbutamol
134. Efecto bronchodilatador de la terbutalina inhalada con y sin extensor en ninos asmaticos
135. Effect of an aerosol delivery system on bronchodilator activity
136. Reduction of morbidity in asthmatic children given a spacer device
137. A comparative study of the inhaled dry powders of salbutamol and fenoterol and their delivery systems
138. Bronchospasmolytic effects of salbutamol as powder inhalation in patients with reversible bronchial obstruction
139. A new spacer device for administration of inhaled salbutamol: Use in elderly asthmatics
140. Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler
141. Influence de la chambre d'inhalation sur la bronchodilatation chez l'enfant asthmatique
142. Cumulative dose response relationship of terbutaline delivered by three different inhalers
143. Comparison of two chamber devices in patients using a metered-dose inhaler with satisfactory technique
144. A comparison of the clinical efficacy and patient acceptability of terbutaline Turbuhaler and salbutamol Rotahaler, in adult patients with asthma
145. Clinical efficacy and safety of the Accuhaler compared with the pressurized metered-dose inhaler (MDI) for the delivery of a single dose of Ventolin (salbutamol) 200 micrograms in adult asthmatics
146. Effect of an extension tube on the bronchodilator efficacy of terbutaline delivered from a metered dose inhaler
147. Bronchodilator effect of salbutamol via the volumatic in children
148. The spacehaler for delivery of salbutamol: A comparison with the standard metered-dose inhaler plus volumatic spacer device
149. Histamine-induced bronchoconstriction is equally relieved by easihaler and diskhaler salbutamol powder inhalers
150. Twenty-eight day double blind safety of an HFA-134a inhalation aerosol system in healthy subjects
151. Randomised cross-over comparison of five inhaler systems for bronchodilator therapy
152. Asthma control and morbidity: A comparison of inhaler devices
153. Comparison of the bronchodilator effect of terbutaline inhaled from a spacer and from Turbuhaler in asthmatic adults
154. Clinical trial of a modified inhaler for pressurized aerosols
155. Childhood asthma: Improved efficacy of pressurized terbutaline aerosol by use of a 750-ml spacer
156. Terbutaline from an ordinary pressurized aerosol or via a 750 ml spacer: A comparative long-term trial in two 4-week periods
157. Dry powder inhalers are bioequivalent to metered-dose inhalers
158. Relative bioavailability of salbutamol to the lung following inhalation via a novel dry powder inhaler and a standard metered dose inhaler
159. A novel breath activated (Autohaler) simplifies metered dose inhaler technique while delivering a consistent dose of medication
160. A low cost spacer device used for asthma treatment in a Calcutta street clinic to improve efficacy of metered dose inhalers
161. A comparison of two delivery devices on the bronchodilatory effects of procaterol from a metered dose inhaler
162. 'Nebular' in der behandlung von kindern mit asthma bronchiale: Wirkungsvergleich mit zwei anderen applikationsformen
163. Bronchodilator effects of a fenoterol metered dose inhaler and fenoterol powder inhaler in asthmatics with poor inhalation technique
164. Long-term effects of a tube extension on bronchodilator treatment with pressurized aerosol
165. Comparison of bronchodilating effects of two salbutamol dry powder inhalers in asthmatic patients
166. Evaluation of inhalation aids of metered dose inhalers in asthmatic children
167. A multicentre comparison of the efficacy of terbutaline turbuhaler and salbutamol pressurized metered dose inhaler in hot, humid regions
168. Lung delivery of salbutamol by dry powder inhaler (Turbuhaler) and small volume antistatic metal spacer (Airomir CFC-free MDI plus NebuChamber)
169. Relative efficacy of three different inhalers containing salbutamol in patients with asthma
170. Application and efficacy of the multi-dose powder inhaler, Easyhaler, in children with asthma
171. Assessment of the acceptability of a new salbutamol multidose dry powder (DPI) in patients with asthma
172. Effect of terbutaline on mucociliary clearance in asthmatic and healthy subjects after inhalation from a pressurized inhaler and a dry powder inhaler
173. Comparison of the bronchodilator effect of inhaled salbutamol powder and pressurized salbutamol aerosol
174. Comparison of the bronchodilator response to albuterol administered by the opithaler, the aerochamber, or by metered dose inhaler alone
175. Lung deposition of fenoterol and flunisolide delivered using a novel device for inhaled medicines. Comparison of respimat with conventional metered-dose inhalers with and without spacer devices
176. Assessment of patient acceptance and inhalation technique of a pressurized aerosol inhaler and two breath-activated devices
177. Domiciliary comparison of terbutaline treatment by metered dose inhaler with and without conical spacer in severe and moderately severe chronic asthma
178. Terbutaline in asthmatic children - A comparison of the conventional 'inhaler' and 'spacer' methods of administration
179. Influence of an extension tube on the bronchodilator efficacy of terbutaline delivered from a metered dose inhaler
180. Aerosol treatment of bronchoconstriction in children with or without a tube spacer
181. Treatment of acute bronchoconstriction in children with use of a tube spacer aerosol and dry powder inhaler
182. Use of tube spacer to improve the efficacy of metered-dose inhaler in asthmatic children
183. Pulmonary response to a bronchodilator delivered from three inhalation devices
184. Determining equivalence of inhaled medications
185. Des MAGhaler - Ein neuartiger treibgasfreier inhalatortyp - Funktionsbeschreibung und erste klinische daten mit dem wirkstoff salbutamol
186. A device for overcoming discoordination with metered-dose inhalers
187. Influence du dispositif d'inhalation sur la qualite de vie des patients asthmatiques: Substitution des aersols doseurs habituels par le turbuhaler
188. Delivery of albuterol aerosol by aerochamber to young children
189. Evaluation of a new spacer device for drug inhalation
190. Probability of particle and salbutamol deposition in the respiratory tract: Comparison between MDI and Autohaler
191. Efecto en el VEF1 al administrar salbutamol con la camara de retencion, espaciador e inhalador de dosis medida
192. Etude comparative de maxair autohaler versus ventodisks chez des patients asthmatiques mauvais coordinateurs
193. Comparison between bricanyl turbuhaler and ventolin metered dose inhaler in the treatment of exercise-induced asthma in adults
194. A double-blind placebo controlled comparison of inhalation from a standard metered dose inhaler and a new multi-dose dry powder inhaler
195. A comparison of incremental doses of salbutamol delivered by a standard metered dose inhaler (MDI) or a new multidose dry powder inhaler (DPI) to healthy volunteers
196. Bioequivalence of metered-dose inhaled medications
197. Efficacy of a simple DIY spacer with a metered dose inhaler in asthma
198. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and turbuhalers
199. Inhaled terbutaline administered via a spacer fully prevents exercise-induced asthma in young asthmatic subjects: A double-blind, randomised, placebo-controlled study
200. Terbutaline via turbuhaler is effective in reversing metacholine-induced bronchoconstriction
201. Proventil HFA provides bronchodilation comparable to ventolin over 12 weeks of regular use in asthmatics
202. Comparison of inhaled albuterol powder and aerosol in asthma
203. Clinical equivalence of a novel non-chlorofluorocarbon-containing salbutamol sulfate metered-dose inhaler and a conventional chlorofluorocarbon inhaler in patients with asthma
204. Proventil HFA provides protection from exercise-induced bronchoconstriction comparable to proventil and ventolin
205. Clinical comparability of albuterol delivered by the breath-actuated inhaler (Spiros) and albuterol by MDI in patients with asthma
206. The protective effect of salbutamol inhaled using different devices on methacholine bronchostriction
207. A novel multiple dose powder inhaler. Salbutamol powder and aerosol give equal bronchodilation with equal doses
208. A comparison between aerosol and inhaled powder administration of fenoterol in adult asthmatics
209. Bronchodilator effects of dry salbutamol powder administered by Rotahaler
210. Terbutaline via pressurized metered dose inhaled (P-MDI) and turbuhaler in highly reactive asthmatic patients
211. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler
212. Cumulative dose-response study of non-CFC propellant HFA 134a salbutamol sulfate metered-dose inhaler in patients with asthma
213. Bronchodilator responses to salbutamol using diskhaler versus metered-dose inhaler
214. Comparison of inhaled terbutaline administered by either the turbuhaler dry powder or a metered-dose inhaler with spacer in preschool children with asthma
215. Salbutamol: Comparison of bronchodilating effect of inhaled powder and aerosol in asthmatic subjects
216. Ipratropium bromide (Atrovent) as inhalation powder. A double-blind study of comparison with ipratropium as a pressure aerosol in patients with reversible airways obstruction
217. Equivalent bronchodilation with salbutamol given via pMDI or turbuhaler
218. Evaluation of a novel salbutamol dry powder inhaler: Clinical equivalence to a standard metered dose inhaler and in-use stability
219. Comparative efficacy and safety of albuterol sulfate spiros inhaler and albuterol metered-dose inhaler in asthma
220. Clickhaler (a novel dry powder inhaler) provides similar bronchodilation to pressurized metered-dose inhaler, even at low flow rates
221. Bronchodilator delivery from Gentlehaler, a new low-velocity pressurized aerosol inhaler
222. Easyhaler, a novel multiple dose powder inhaler: Clinically equivalent to salbutamol metered dose inhaler and easier to use
223. Efficacy and safety of salbutamol delivered by a novel multidose dry powder inhaler (DPI) and a pressurized metered dose inhaler (MDI) in paediatric asthma
224. A multiple dose powder inhaler (turbuhaler) compared with a conventional aerosol
225. Protection against methacholine bronchoconstriction to assess relative potency of inhaled beta-2 agonists
226. A new multiple dose powder inhaler, (Turbuhaler), compared with a pressurized inhaler in a study of terbutaline in asthmatics
227. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma
228. A placebo controlled comparison of the dose-response effects of salbutamol sulphate in chlorofluorocarbon (CFC) vs hydrofluoroalkane (HFA-134a) propellants in asthmatics
229. Ventilation effects of fenoterol powder and freon-propelled aerosol in patients with asthma
230. The bronchoprotective efficacy of salbutamol inhaled from a new metered-dose powder inhaler compared with a conventional pressurized metered-dose inhaler connected to a spacer
231. Single dose comparison between a novel multiple dose powder inhaler and a conventional metered dose inhaler in asthmatic patients
232. GR106642X: A new, non-ozone depleting propellant for inhalers
233. Comparison of a novel salbutamol multidose powder inhaler with a salbutamol metered dose inhaler in patients with asthma
234. Proventil HFA and ventolin have similar safety profiles during regular use
235. Comparison of inhaled salbutamol powder and aerosol in asthmatic patients with low peak expiratory flow level
236. Comparison of inhaled terbutaline either via MDI or via a new DPI Turbuhaler
237. Comparative assessment of a new breath-actuated inhaler in patients with reversible airways obstruction
238. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurized metered dose inhaler, as a dry powder and as a nebulised solution
239. BTS NPG (Nebuliser Project Group of the BTS Standards of Care Committee). Running a domiciliary nebuliser service
240. Comparison of holding chambers and nebulisers for beta-agonists in acute asthma
241. A dose response study of inhaled terbutaline administered via Nebuhaler or nebuliser to asthmatic children
242. Nebuhaler versus wet aerosol for domiciliary bronchodilator therapy (Adults)
243. Salbutamol: Tablets, inhalational powder or nebuliser?
244. Die inhalation von beta-stimulatoren: Wirkungsvergleich zwischen sechs vershiedenen inhalationsgeraten
245. Comparative efficacy of different methods of nebulising terbutaline
246. Bronchodilator effects of nebulized fenoterol. A comparison with isoproterenol
247. Salbutamol inhalation in chronic asthma brochiale: Dose aerosol vs jet nebulizer
248. Bronchodilation with a metered-dose inhaler plus an extension, using tidal breathing vs jet nebulisation
249. Dose-response comparison of ipratromium bromide from metered-dose inhaler and by jet nebulisation
250. Comparison of a 750ml spacer and a nebulizer in domiciliary treatment of severe chronic asthma with terbutaline
251. Cumulative dose-response study comparing terbutaline pressurized aerosol administered via a pearshaped spacer and terbutaline in a nebulized solution
252. Pressurized aerosol with conical spacer is an effective alternative to nebuliser in chronic stable asthma
253. High-dose inhaled terbutaline in the management of chronic severe asthma: Comparison of wet nebulisation and tube-spacer delivery
254. Effect of bronchodilator therapy administered by canister versus jet nebulizer
255. Terbutaline aerosol from a metered dose inhaler with a 750-ml spacer or as a nebulized solution
256. Relative amount of albuterol delivered to lung receptors from a metered-dose inhaler and nebulizer solution. Bioassay by histamine bronchoprovocation
257. Drug delivery in asthma: A comparison of spacers with jet nebuliser
258. Broncodilatacao induzida pelo fenoterol em asmaticos: Comparacoa entre nebulizador a jato e espacador
259. Bronchodilatacioni efekat salbutamola aplikovanog direktno rasprsivacem i preko spacera
260. A long-term prospective assessment of home nebulizer treatment
261. A long-term study of symptoms, spirometry and survival amongst home nebulizer users
262. MDI with spacer vs nebulizer in pediatric asthma
263. Inhalation therapy in asthma: Nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children
264. Comparison of the bronchodilator effects of salbutamol delivered via a metered-dose inhaler with spacer, a dry powder inhaler, and a jet nebulizer in patients with chronic obstructive pulmonary disease
265. Terbutaline in COPD comparison between turbuhaler and chlorofluorocarbon (CFC) inhaler
266. The effects of salbutamol aerosol on lung function in patients with pulmonary emphysema
267. Comparison of three techniques of inhalation on the airway response to terbutaline
268. A placebo-controlled comparison between the bronchodilatory effects of ipratropium bromide inhaled as a dry powder and by metered dose inhaler in chronic obstructive pulmonary disease
269. Effect of terbutaline on exercise capacity and pulmonary function in patients with chronic obstructive pulmonary disease
270. Comparability of albuterol delivered by a piezo-electric device versus metered dose inhaler in patients with chronic obstructive airways disease
271. Ein neues inhalations system zur bronchodilation
272. Fenoterol inhalation powder and aerosol
273. Evaluation of the effectiveness of four different inhalers in patients with chronic obstructive pulmonary disease
274. Comparison of a new multidose powder inhaler (diskus/accuhaler) and Turbuhaler regarding preference and ease of use
275. Turbuhaler: A new powder inhaler for administration of drugs to the airways
276. Nebuhaler or nebulizer for high dose bronchodilator therapy in chronic bronchitis: A comparison
277. Nebulizer vs spacer for bronchodilator delivery in patients hospitalised for acute exacerbations of COPD
278. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-centre study
279. Terbutaline powder inhalation from Bricanyl Turbuhaler compared to terbutaline as nebulizer solution in severe chronic airways obstruction
280. Terbutaline inhalations by the Turbuhaler as replacement for domiciliary nebulizer therapy in severe chronic obstructive pulmonary disease
281. Salbutamol powder inhaled from the diskhaler compared to salbutamol as nebulizer solution in severe chronic airways obstruction
282. Changes in blood gas levels after Nebuhaler and nebulizer administration of terbutaline in severe chronic airway obstruction
283. Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation
284. Comparison of a hand-held nebulizer with a metered dose inhaler-spacer combination in acute obstructive pulmonary disease
285. Comparison of outpatient nebulized vs metered dose inhaler terbutaline in chronic airflow obstruction
286. Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute airflow obstruction
287. High dose salbutamol in chronic airflow obstruction: Comparison of nebuliser with Rotacaps
288. Bronchodilator therapy for chronic obstructive pulmonary disease
289. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease
290. Home nebulizers: Can optimal therapy be predicted by laboratory studies?
291. The adult patient's difficulties with inhalers
292. Evaluation of the long-term effectiveness of three instruction modes for inhaling medicines
293. The effect of a structured education program on knowledge and psychomotor skills of patients using beclomethasone dipropionate aerosol for steroid dependant asthma
294. Controlled trial of a home and ambulatory program for asthmatic children
295. Evaluation randomised de deux methodes d'appentissage de l'utilisation des aerosols-doseurs
296. A one-year prospective audit of an asthma education programme in an out-patient setting
297. Evaluation of education provided by a pharmacist to hospitalized patients who use metered-dose inhalers
298. Evaluating the outcome of two teaching methods of breath actuated inhaler in an inner city asthma clinic
299. The value of demonstration and role of the hospital pharmacist in teaching the correct use of pressurized bronchodilators
300. Effect of pharmacist counselling on ambulatory patients' use of aerosolized bronchodilators
301. Effects of instruction by practice assistants on inhaler technique and respiratory symptoms of patients. A controlled randomized videotaped intervention study
302. A controlled trial of two forms of self-management education for adults with asthma
303. Evaluation of the efficacy and cost-effectiveness of health education methods to increase medication adherence among adults with asthma
304. Faulty use of canister nebulizers for asthma
305. Objective measurements of compliance in asthma treatment
306. Evaluation of the efficacy of a hospital-based asthma education programme in patients of socioeconomic status in Hong Kong
307. Evaluation of a school-based asthma education program for inner-city children
308. Evaluation de la manipulation en pratique courante d'un aerosol-doseur declenche par l'inspiration (systeme Autohaler)
309. Use and misuse of metered-dose inhalers by patients with chronic lung disease. A controlled, randomized trial of two instruction methods
310. Evaluation of an educational program for asthma control in adults
311. Evaluation of an auditory feedback equipped metered dose inhaler
312. Pressurized aerosol inhalers: The cost of misuse
313. Proper aerosol inhalation technique for delivery of asthma medications
314. An education programme that improves the psychomotor skills needed for metaproterenol inhaler use
315. Inhaler use in chronic obstructive pulmonary disease
316. Assessment of patient acceptance and inhalation technique of a pressurized aerosol inhaler and two breath-actuated devices
317. Inhalation technique of 166 adult asthmatics prior to and following a self management program
318. Aerosol inhaler technique in children with asthma
319. Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device
320. Assessment of the inhalation technique in asthmatic patients: A comparative study of three aerosol devices
321. A comparison of breath-actuated and conventional metered-dose inhaler inhalation techniques in elderly subjects
322. Inhaler technique of elderly patients: Comparison of metered-dose inhalers and large volume spacer devices
323. Is the correct use of dry powder inhaler (Turbohaler) age dependent?
324. Treatment with inhaled steroids in asthma and chronic bronchitis: Long-term compliance and inhaler technique
325. Survey of the clinical use of pressurized aerosol inhalers
326. An audit of inhaler technique among asthma patients of 34 general practitioners
327. Poor inhalation technique, even after inhalation instructions, in children with asthma
328. An audit of antiasthmatic drug inhalation technique and understanding
329. Evaluation of conventional press-and-breathe metered-dose inhaler technique in 501 patients
330. Clinical consequences of inadequate inhalation technique in asthma therapy
331. Assessing the use of metered dose inhalers by adults with asthma
332. Errors in inhalation technique and efficiency in inhaler use in asthmatic children
333. Medical personnel and patient skill in the use of metered dose inhalers: A multicentric study
334. Effectiveness assessment of three inhalation devices in asthmatics: Comparative study among patients trained at various assistential levels
335. Metered-dose inhaler technique of patients in an urban ED: Prevalence of incorrect technique and attempt at education
336. Misuse of metered-dose inhalers in hospitalized patients
337. Decision analysis in the selection, design and application of clinical and health services research
338. Variations in the prevalence of respiratory symptoms, self reported asthma attacks and use of asthma medication in the European Community Respiratory Health Survey
339. Self management education and regular practitioner review for adults with asthma
340. Asthma in Greenwich, UK: Impact of the disease and current management practices
341. Improving the quality of reporting of randomized controlled trails: The CONSORT statement